OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Pulmonary Medicine is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
The persistent problem of persistent air-leaks: approach to management	78
Thoracic empyema: aetiology, diagnosis, treatment, and prevention	45
Cardiac sarcoidosis and neurosarcoidosis – multidisciplinary approach for diagnosis	35
Home monitoring in asthma: towards digital twins	30
Spirometry, computed tomography, comorbidities, oxygen therapy and other topics in chronic obstructive pulmonary disease and an update on silicosis	28
Bronchoscopic treatment of early-stage peripheral lung cancer	27
The role of PET in the management of sarcoidosis	26
Digital outcome measures in pulmonary clinical trials	21
Lung microbiome, gut–lung axis and chronic obstructive pulmonary disease	21
The evolving role of radiological imaging in cystic fibrosis	21
Improving care in lung cancer surgery: a review of quality measures and evolving standards	20
Evolving nutritional needs, obesity, and overweight status in cystic fibrosis	19
Group 2 pulmonary hypertension: from diagnosis to treatment	18
Genetic background of pulmonary (vascular) diseases – how much is written in the codes?	18
Disease-specific gaps within fungal respiratory tract infections: clinical features, diagnosis, and management in critically ill patients	17
Novel interventions on the tricuspid valve: how to consider the pulmonary circulation?	17
Micro-RNA in obstructive sleep apnoea: biomarker of cardiovascular outcome?	16
Bronchoscopic diagnosis of peripheral lung lesions	15
The role of chest computed tomography in the evaluation and management of chronic obstructive pulmonary disease	15
Implementation of digital home monitoring and management of respiratory disease	15
Elexacaftor–tezacaftor–ivacaftor use after solid organ transplant	14
Asthma in pregnancy: a review of recent literature	14
Lung transplant referral considerations for individuals with cystic fibrosis	14
Considerations and clinical management of infections in sarcoidosis	14
Editorial introductions	14

Paediatric asthma - all that wheezes is not necessarily asthma - current diagnostic and management strategies	13
The future of clinical trials in idiopathic pulmonary fibrosis	13
Editorial introductions	13
Household air pollution and respiratory health in Africa: persistent risk and unchanged health burdens	12
An update of palliative care in lung transplantation with a focus on symptoms, quality of life and functional outcomes	12
Management of patients with idiopathic pulmonary fibrosis and lung cancer: challenges in clinical practice	12
Sarcoidosis and frailty: recognizing factors that foster holistic resilience	12
Mechanisms relating to sleeping position to the endotypes of sleep disordered breathing	12
Food for thought: optimal diet in patients with asthma and chronic obstructive pulmonary disease	12
The modern landscape of fertility, pregnancy, and parenthood in people with cystic fibrosis	12
Co-morbid insomnia and sleep apnea (COMISA): recent research and future directions	12
Cystic fibrosis liver disease in the post-modulator era	12
Casting light on the many facets of sarcoidosis	12
Progress for all: addressing disparities in sarcoidosis	12
Acute rejection post lung transplant	11
Chronic obstructive pulmonary disease risk assessment tools: is one better than the others?	11
Tobacco treatment in the setting of lung cancer screening	11
Digital inhalers for asthma management	11
What causes cough in pulmonary fibrosis, and how should we treat it?	10
Patterns of progression in non-IPF fibrotic interstitial lung disease	10
Home monitoring of coronavirus disease 2019 patients in different phases of disease	10
Imaging in peripheral bronchoscopy	10
Therapeutic pipeline for individuals with cystic fibrosis with mutations nonresponsive to current cystic fibrosis transmembrane conductance regulator modulators	10
Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease	10
Effectiveness and safety of coronavirus disease 2019 vaccines	10
Obstructive lung diseases burden and COVID-19 in developing countries: a perspective	9
Exhaled breath analysis in interstitial lung disease	9
Multidisciplinary care in nonmalignant central airway obstruction	9
Editorial: Silicosis, asbestos-related diseases, war-site exposures and a variety of topics in chronic obstructive pulmonary disease	9
Novel insights in fibrotic pulmonary sarcoidosis	9
Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators	9
Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdown	9
Editorial: Are we ready for prime time?	9
Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort	9
Altered pharmacology and toxicology during ageing: implications for lung disease	8
Telerehabilitation in pulmonary diseases	8
Pulmonary rehabilitation in idiopathic pulmonary fibrosis	8
Editorial: ‘What is your occupation?’: historical snippets	8
Infection control in cystic fibrosis: evolving perspectives and challenges	8
Interventional pulmonology: reflection on the past, perfecting the present and innovating for the future	8
Role of extracorporeal membrane oxygenation and surgical embolectomy in acute pulmonary embolism	8
The current understanding and future directions for sputum microbiome profiling in chronic obstructive pulmonary disease	8
Epigenetics and aging: relevance for sleep medicine	8
Pediatric interventional bronchoscopy: from early limitations to achievable opportunities	8
Transbronchial biopsy vs. bronchoalveolar lavage in interstitial lung disease	8
The changing landscape of infections in the lung transplant recipient	8
The association of preexisting severe asthma with COVID-19 outcomes	7
Telehealth and virtual health monitoring in cystic fibrosis	7
Occupational exposures and sarcoidosis: current understanding and knowledge gaps	7
Advancing bacteriophages as a treatment of antibiotic-resistant bacterial pulmonary infections	7

Adenotonsillectomy: the good, the bad and the unknown	7
Right ventricular assessment in pulmonary hypertension	7
Military deployment-related respiratory problems: an update	7
Prader–Willi syndrome: an update	7
Rigid versus flexible bronchoscopy in interventional pulmonology: perspective from the master clinicians	7
Ergonomics in bronchoscopy	7
Approach to the hospitalized patient with pulmonary arterial hypertension	7
Pulmonary embolism work-up in chronic obstructive pulmonary disease exacerbations: what is the best strategy for clinicians?	7